The latest headlines across every section, pulled from official and open-access sources.
Sugar-sweetened beverages (SSBs) and fruit juice consumption were positively associated with a higher risk of hypertension independent of diet quality, physical activity and other factors, according to results from the ongoing GUTS study published June 22 in Circulation.
There was no significant difference in procedural success, major in-hospital complications or stroke at one year in patients undergoing transcatheter left atrial appendage occlusion (LAAO) with reduced LVEF; however, these patients did exhibit higher mortality at one year...
AC01, a novel oral calcium-sensitizing isotope and ghrelin receptor agonist designed to increase myocardial contractility, appeared safe and well-tolerated over a 28-day treatment period in patients with heart failure with reduced ejection fraction (HFrEF), according to results from a phase 1b/2a randomized trial published June 24 in The Lancet.
Sun Life extends collaboration with the American Diabetes Association to continue support of youth initiative Project Power mcarmody Tue, 06/30/2026 - 18:25 Press release Sun Life extends collaboration with the American Diabetes Association to continue support of youth initiative Project Power WELLESLEY, Mass. and MERRIFIELD, Va. June 29, 2026 Sun Life U.S. has renewed its national collaboration with the American Diabetes Association® (ADA), continuing its support of Project Power for youth, a comprehensive national initiative designed to engage, educate and empower young people to embrace…
The following are the medical, statistical, and clinical pharmacology reviews of pediatric studies conducted in response to a Written Request issued under the BPCA and pediatric assessments conducted under PREA.
During 2022-2024, a total of 13,507 clinical C. auris cases were reported to CDC, increasing from 2,882 in 2022 to 4,428 in 2023 and 6,197 in 2024, with smaller annual percentage increases over time.
The table below lists qualified Clinical Outcome Assessments (COA). The tables include legacy projects (those submitted prior to passage of the 21st Century Cures Act), as well as those submitted as part of the newer section 507 process (referring to section 507 of the Federal Food, Drug and Cosmeti
Clinical Outcome Assessments (COA) Qualification Program Submissions
Coming on the heels of a $130 million fundraising round just four months ago, bone-focused Angitia Biopharmaceuticals has pivoted away from its lead asset to structure its pipeline around two earlier-stage drug candidates.
Resources and information for requestors interested in CDER’s Clinical Outcome Assessments (COA) Qualification Program. This update contains the Letter of Intent Template for the COA Qualification Program, as described under section 507 of the Federal Food, Drug, and Cosmetic Act.
In this month’s pivot podcast, I speak to the chief medical officer of San Francisco-based Vynca, an innovative company in the world of palliative care that is providing serious disease management at home. The post MedCity Pivot Podcast: The Evolution of Palliative Care at Home appeared first on MedCity News .
Pacira’s iovera device uses cold therapy for targeted pain relief. An analyst said the addition complements Zimmer Biomet’s portfolio.
List of Field Safety Notices from 22 to 26 June 2026.
Christina Zamarro will take over the role in July after spending nearly 20 years at Goodyear Tire & Rubber Company, most recently serving as its CFO.
Even with robust evidence demonstrating their efficacy and safety, direct oral anticoagulants (DOACs) continue to be underused and, at times, inappropriately dosed, particularly in patients at elevated thrombotic risk.
A new ACC Scientific Statement focused on the management of atherosclerotic cardiovascular disease, aims to help clinicians overcome the perpetual challenge of balancing the risk of ischemia with the risk of bleeding in this patient population.
by Seena Fazel Despite public health strategies focusing on men’s mental health and suicide risk, rates of suicide among men remain concerningly high. Targeted, specialized approaches for high-risk individuals should be prioritized alongside broader population-level strategies. Despite public health strategies focusing on men’s mental health and suicide risk, rates of suicide among men remain concerningly high. In this Editorial, Seena Fazel outlines why targeted, specialized approaches for high-risk individuals should be prioritized alongside broader population-level strategies.
by Margaret M. Byrne, Jill M. Kolesar Precision oncology is revolutionizing cancer care, but isn’t reaching enough patients. Molecular tumor boards (MTBs) translate complex genomic data to more effectively inform personalized care, and a new meta-analysis shows they boost clinical outcomes. But how can we feasibly and equitably expand the use of MTBs? Molecular tumor boards translate complex genomic data to more effectively inform personalized care, and a new meta-analysis shows they boost clinical outcomes. In this Perspective, Margaret Byrne and Jill Kolesar discuss how we may feasibly and…
This requires more than deploying the right technology. It demands a reevaluation of how these systems fit into the healthcare environment and how to bring patients and staff along. The post Hospitals Have Always Had Eyes — AI is Giving Them a Brain appeared first on MedCity News .
In patients with atrial fibrillation (AFib) with normal cardiac function and sinus rhythm after catheter ablation, 12% who discontinued guideline-directed medical therapy (GDMT) experienced heart failure (HF) deterioration, while drug-related complications were more likely among patients who continued GDMT...
We should ask a more nuanced question than “does AI work in drug discovery.” Rather, we should ask which approaches are about to be proven, and which are about to be exposed, because the field is several bets, and they are not equally sound. The post The AI Drug Discovery Race Is Heating Up, Not In the Way You Think appeared first on MedCity News .
To meet the modern patient where they are, we must pivot away from managing chronic diseases to preventing them entirely, replacing a legacy system of triage with a new model that emphasizes proactive, personalized prevention. The post From Management to Personalized Prevention: The Phase Shift in Chronic Disease appeared first on MedCity News .
More than 40 million Americans live with migraine and other headache disorders. They include children trying to stay in school, workers trying to remain employed, parents caring for their families, veterans and first responders living with post-traumatic headache, and more. The post Headache Disorders Have Been Part of the American Story for 250 Years appeared first on MedCity News .
FDA issues compounding risk alerts to communicate information to alert health care professionals to adverse events and outbreaks related to compounded drugs so that practitioners can more effectively protect patients from unsafe, ineffective, and poor quality compounded medicines.